Komori
Amvis Holdings (7071) · RiskRestated

Leakage of Users’ Medical Information and Management Information

First written in FY2019. 15 of 17 entries say "Restated". Latest entry: FY2026-H1.

17entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2022-Q3RestatedFY2023-Q2 – FY2026-H12019: 12020: 420202021: 420212022: 420222023: 220232024: 120242025: 020252026: 12026
Same theme, other companies
Confidentiality and Personal Information Leakage RiskA theme 1043 companies write about · 1055 as a headwind · 3 as a tailwind

The whole theme swung hardest in 2026: 13 of 71 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1058 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「During the interim consolidated accounting period, there were no new business or other risks and no material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  2. FY2024-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  3. FY2023-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  4. FY2023-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  5. FY2022ReframedAnnual report

    「The company handles information on a large number of users, including information such as medical histories and treatment status that must be subject to particularly stringent controls. In addition, the Group's administrative departments hold various types of internal information, including management information.」

    In addition to users' medical information, the company explicitly identifies internal information, including management information, held by administrative departments and clarifies the scope of information management risks.
  6. FY2022-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  7. FY2022-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  8. FY2022-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  9. FY2021RestatedAnnual report

    「The information includes medical histories and treatment status, among other information that must be subject to particularly stringent controls.」

    The company continues to disclose the risk of leakage of users' medical and management information and measures including training, confidentiality undertakings and access restrictions.
  10. FY2021-Q3RestatedAnnual report

    「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  11. FY2021-Q2RestatedAnnual report

    「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that management recognizes could materially affect the financial position, operating results and cash flows of the consolidated companies, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  12. FY2021-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    A summary statement says there have been no material changes regarding the leakage of users' medical and management information.
  13. FY2020RestatedAnnual report

    「The information includes medical histories and treatment status, among other information that must be subject to particularly stringent controls.」

    The company continues to disclose the risk of leakage of users' medical and management information and is reconfirming measures including training, confidentiality undertakings and access restrictions.
  14. FY2020-Q3RestatedAnnual report

    「During the cumulative third-quarter period, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  15. FY2020-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  16. FY2020-Q1RestatedAnnual report

    「During the cumulative first quarter of the fiscal year, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    The company states that there have been no material changes regarding the leakage of users' medical and management information.
  17. FY2019First statedAnnual report

    「The information includes medical histories and treatment status, among other information that must be subject to particularly stringent controls.」

    The company seeks to reduce the risk of information leakage through employee training, confidentiality undertakings, segregation of access areas and access restrictions for servers and disks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Amvis Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Leakage of Users’ Medical Information and Management Information | Amvis Holdings,Inc. (7071) | Komori